Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Main Authors: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1986
|
Similar Items
-
Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
by: Roberto Galea, et al.
Published: (2023-09-01) -
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
by: Turpie AGG
Published: (2014-03-01) -
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
by: Andrei Viktorovich Fonyakin, et al.
Published: (2012-09-01) -
Long-term oral anticoagulation for atrial fibrillation in low and middle income countries
by: Venkatakrishnan Ramakumar, et al.
Published: (2021-03-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)